Immunotherapy for lung adenocarcinoma (LUAD) is considered to be a promising treatment option. but only a minority of patients benefit from it. Therefore. it is essential to clarify the regulation mechanism of the tumor immune microenvironment (TIM) of the LUAD. https://www.ealisboa.com/